Clarian Health’s recent rebranding to Indiana University Health has been good business for at least three companies in Indianapolis’ so-called measured-marketing sector. Such firms help a company overhaul its website and make changes to the “tweetosphere” and other social media channels.
West Lafayette-based Endocyte Inc. announced Friday that it has closed on $26 million in equity financing to help the company
continue developing cancer-fighting drugs.
The city’s largest hospital system will try its hand at high-stakes investing. Clarian Health Partners is forming its own
venture-capital fund, called Clarian Health Ventures, to invest in fast-growing companies and finance the commercialization
of research conducted at Clarian or by its staff.
